Elucidating biased signaling in class A GPCRs
Trends in Pharmacological Sciences · 2025-12 · 46 (12) · 1190-1208
DOI: 10.1016/j.tips.2025.10.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025-12. Verfasst von Ningyang Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Signal Transduction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Biased signaling by G protein-coupled receptors (GPCRs) occurs when ligands selectively activate G proteins or β-arrestins, offering therapeutic potential with fewer side effects. In class A GPCRs, which include the targets of approximately one-third of all marketed drugs, the structural basis of this selectivity remains unclear. Recent cryo-electron microscopy studies, supported by real-time functional assays such as bioluminescence resonance energy transfer and NanoLuc Binary Technology, reveal how distinct ligand binding modes reshape receptor conformations to favor specific transducer engagement. Integrating structural and functional insights enables mapping of isoform- and tissue-specific signaling. Here, we review key mechanisms of bias, including microswitch transitions, intracellular interface remodeling, and allosteric modulation, and provide a mechanistic basis for pathway-selective GPCR-targeting therapeutics with improved efficacy and reduced off-target effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Cancer Center and Department of Biophysics, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
- Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: lzhu@mcw.edu.
- Cancer Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI 53226, USA. Electronic address: weiliu@mcw.edu.
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
- Medical College of Wisconsin Cancer Center
- Medical College of Wisconsin
- Advancing a Healthier Wisconsin Endowment
Zitieren
APA
Xu, N., Legall, E., Johnson, R. H., Zhu, L., & Liu, W. (2025). Elucidating biased signaling in class A GPCRs. Trends in Pharmacological Sciences, 46(12), 1190-1208. https://doi.org/10.1016/j.tips.2025.10.008
Vancouver
Xu N, Legall E, Johnson RH, Zhu L, Liu W. Elucidating biased signaling in class A GPCRs. Trends in Pharmacological Sciences. 2025;46(12):1190-1208. doi:10.1016/j.tips.2025.10.008
BibTeX
@article{Xu2025,
author = {Xu, Ningyang and Legall, Edwin and Johnson, Roger H and Zhu, Lan and Liu, Wei},
title = {Elucidating biased signaling in class A GPCRs},
journal = {Trends in Pharmacological Sciences},
year = {2025},
volume = {46},
number = {12},
pages = {1190--1208},
doi = {10.1016/j.tips.2025.10.008}
}
EUVIMED